Related Experiment Video

Updated: Aug 15, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2

Lara Kunschner¹, Thomas F Scott

¹Drexel University College of Medicine, Pittsburgh, PA, USA.

|November 9, 2005

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN.

Multiple sclerosis and related disorders·2022

Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis.

Journal of the neurological sciences·2021

Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate.

Therapeutic advances in neurological disorders·2021

Real world prognosis in MS: does early versus late diagnosis matter?

Neurological research·2021

Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.

International journal of MS care·2020

The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.

Journal of the neurological sciences·2020

See all related articles